North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth Drivers by 2029

by Michael Jaikishan on Apr 13, 2023 Sports & Recreation 168 Views

North America circulating tumor cells (CTC) liquid biopsy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021. The high prevalence of chronic diseases and increasing R&D activities for its effective application is likely to be the major drivers which propel the demand of the market in the forecast period.

 

The liquid biopsy is a non-invasive blood test which detects circulating tumor cells and tumor DNA fragments which are released into the blood from primary tumors and metastatic sites. It is a simple and precise alternative to surgical biopsy procedure, which allows surgeon to detect cancer at a very early stage.

 

The circulating tumor cells are a rare sub-set of cells which function as a seed of metastases. It is found in blood of patients who have developed solid tumors. The testing of circulating tumor cells allows the detection and quantification of tumor cells in the blood of cancer patients. The various types of biological phenotypes of circulating tumor cells (CTCs) exits includes stem cell-like or mixed, mesenchymal or epithelial. These phenotypes are present in blood in a very small quantity. Due to which, their detection needs a phase of isolation-enrichment. After that, a second phase of detection.

 

North America circulating tumor cells (CTC) liquid biopsy market is analysed and market size information is provided by country, technology, application and end user.

 

Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/north-america-circulating-tumor-cells-ctc-liquid-biopsy-market

 

The countries covered in the North America circulating tumor cells (CTC) liquid biopsy market report are U.S., Canada and Mexico.

 

The U.S. is dominating the circulating tumor cells (CTC) liquid biopsy in the North American region due to rise in number of cancer patients and presence of major players in the market.

 

The major companies providing circulating tumor cells (CTC) liquid biopsy are Eurofins Genomics ( a subsidiary of Eurofins Scientific), MDx Health, Guardant Health, IMMUCOR, Thermo Fisher Scientific, Inc., Menarini Silicon Biosystems, QIAGEN, Exact Sciences Corporation, Myriad Genetics, Inc., LungLife AI, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc. , Natera Inc., ExoDx ( a subsidiary of Bio-Techne Corporation), Biocept, Inc., F. Hoffman-La Roche Ltd. ,FOUNDATION MEDICINE, INC., Lucence Health, Inc., Inivata Ltd, Biolidics Limited, Vortex Biosciences among others.

 

About Data Bridge Market Research:

 

An absolute way to forecast what future holds is to comprehend the trend today!

 

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

 

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

 

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Sports-Recreation/42294-North-America-Circulating-Tumor-Cells-CTC-Liquid-Biopsy-Market-Growth-Drivers-by-2029.html

Reviews

Guest

Overall Rating:

Comments

No comments have been left here yet. Be the first who will do it.
Safety

captchaPlease input letters you see on the image.
Click on image to redraw.

Statistics

Members
Members: 15673
Publishing
Articles: 64,357
Categories: 202
Online
Active Users: 818
Members: 3
Guests: 815
Bots: 4623
Visits last 24h (live): 818
Visits last 24h (bots): 4623

Latest Comments

Thank you for the encouragement! Really needed this today. ????   from https://sprunkedgame.online/ https://sprunkigame.online/
Drive Mad levels are tough yet achievable, striking the perfect balance to keep players coming back. Instant Accessibility: The browser-based format makes it easy to jump in anytime,...
Playing a typical papa's games means making all the delectable fast food and bakery goods in the allotted time. The object of these games is to match the correct ingredients with the correct...
on Oct 29, 2024 about ABC’s Of The RSA and CPR Courses
Pacific Certifications is part of E-Certifications, a leading independent certification body for ISO Certifications, accredited by ABIS (Accreditation Board for International Standards), Product...
on Oct 28, 2024 about muneera
Every Dodger fan will fall in love with the ideal ensemble thanks to the Unisex Dona x Los Angeles varsity Jacket , which is the ideal blend of fashion and utility. The polyester shell provides...